[1] Hernández-Cabanyero C, Amaro C. Phylogeny and life cycle of the zoonotic pathogen Vibrio vulnificus. Environ Microbiol, 2020; 22, 4133−48. doi:  10.1111/1462-2920.15137
[2] Heng SP, Letchumanan V, Deng CY, et al. Vibrio vulnificus: an environmental and clinical burden. Front Microbiol, 2017; 8, 997. doi:  10.3389/fmicb.2017.00997
[3] Baker-Austin C, Oliver JD. Vibrio vulnificus: new insights into a deadly opportunistic pathogen. Environ Microbiol, 2018; 20, 423−30. doi:  10.1111/1462-2920.13955
[4] Leng F, Lin SL, Wu W, et al. Epidemiology, pathogenetic mechanism, clinical characteristics, and treatment of Vibrio vulnificus infection: a case report and literature review. Eur J Clin Microbiol Infect Dis, 2019; 38, 1999−2004. doi:  10.1007/s10096-019-03629-5
[5] Hong GL, Wu B, Lu CJ, et al. Emergency treatment of 16 patients with necrotizing fasciitis caused by Vibrio vulnificus infection complicated with septic shock. Chin Med J (Engl), 2014; 127, 1984−6.
[6] Bolognese AC, Yang WL, Hansen LW, et al. Inhibition of necroptosis attenuates lung injury and improves survival in neonatal sepsis. Surgery, 2018; 164, 110−6. doi:  10.1016/j.surg.2018.02.017
[7] Xu Q, Guo JJ, Li XG, et al. Necroptosis underlies hepatic damage in a piglet model of lipopolysaccharide-induced sepsis. Front Immunol, 2021; 12, 633830. doi:  10.3389/fimmu.2021.633830
[8] Sharma A, Matsuo S, Yang WL, et al. Receptor-interacting protein kinase 3 deficiency inhibits immune cell infiltration and attenuates organ injury in sepsis. Crit Care, 2014; 18, R142. doi:  10.1186/cc13970
[9] Duprez L, Takahashi N, Van Hauwermeiren F, et al. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity, 2011; 35, 908−18. doi:  10.1016/j.immuni.2011.09.020
[10] Kitur K, Parker D, Nieto P, et al. Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage. PLoS Pathog, 2015; 11, e1004820. doi:  10.1371/journal.ppat.1004820
[11] González-Juarbe N, Gilley RP, Hinojosa CA, et al. Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia. PLoS Pathog, 2015; 11, e1005337. doi:  10.1371/journal.ppat.1005337
[12] Yuan Y, Feng Z, Wang J. Vibrio vulnificus hemolysin: biological activity, regulation of vvhA expression, and role in pathogenesis. Front Immunol, 2020; 11, 599439. doi:  10.3389/fimmu.2020.599439
[13] Shuai WZ, Liu JF, Wu CL, et al. Vibrio vulnificus cytolysin induces necroptosis in immortalized bone marrow-derived macrophage through RIP1/MLKL pathway. Med J Chin PLA, 2018; 43, 419−23. (In Chinese
[14] Patoli D, Mignotte F, Deckert V, et al. Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis. J Clin Invest, 2020; 130, 5858−74. doi:  10.1172/JCI130996
[15] Qiu P, Liu Y, Zhang J. Review: the role and mechanisms of macrophage autophagy in sepsis. Inflammation, 2019; 42, 6−19. doi:  10.1007/s10753-018-0890-8
[16] Lee MA, Kim JA, Shin MY, et al. VvpM induces human cell death via multifarious modes including necroptosis and autophagy. J Microbiol Biotechnol, 2015; 25, 302−6. doi:  10.4014/jmb.1501.01007
[17] Malaguarnera L. Influence of resveratrol on the immune response. Nutrients, 2019; 11, 946. doi:  10.3390/nu11050946
[18] Meng TT, Xiao DF, Muhammed A, et al. Anti-inflammatory action and mechanisms of resveratrol. Molecules, 2021; 26, 229. doi:  10.3390/molecules26010229
[19] Li XJ, Yao YJ, Wang SC, et al. Resveratrol relieves chlorothalonil-induced apoptosis and necroptosis through miR-15a/Bcl2-A20 axis in fish kidney cells. Fish Shellfish Immunol, 2020; 107, 427−34. doi:  10.1016/j.fsi.2020.11.007
[20] Xu HC, Lv W, Wang LM, et al. Early protection by resveratrol in rat lung transplantation. Med Sci Monit, 2019; 25, 760−70. doi:  10.12659/MSM.912345
[21] Qin KW, Fu KF, Liu JF, et al. Vibrio vulnificus cytolysin induces inflammatory responses in RAW264.7 macrophages through calcium signaling and causes inflammation in vivo. Microb Pathog, 2019; 137, 103789. doi:  10.1016/j.micpath.2019.103789
[22] Qin KW, Han CF, Zhang H, et al. NAD+ dependent deacetylase Sirtuin 5 rescues the innate inflammatory response of endotoxin tolerant macrophages by promoting acetylation of p65. J Autoimmun, 2017; 81, 120−9. doi:  10.1016/j.jaut.2017.04.006
[23] Khoury MK, Gupta K, Franco SR, et al. Necroptosis in the pathophysiology of disease. Am J Pathol, 2020; 190, 272−85. doi:  10.1016/j.ajpath.2019.10.012
[24] Li G, Wang MY. The role of Vibrio vulnificus virulence factors and regulators in its infection-induced sepsis. Folia Microbiol (Praha), 2020; 65, 265−74. doi:  10.1007/s12223-019-00763-7
[25] Tang R, Xu J, Zhang B, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol, 2020; 13, 110. doi:  10.1186/s13045-020-00946-7
[26] Yuan JY, Amin P, Ofengeim D. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat Rev Neurosci, 2019; 20, 19−33. doi:  10.1038/s41583-018-0093-1
[27] Zhang C, Feng YS, Qu SL, et al. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53. Cardiovasc Res, 2011; 90, 538−45. doi:  10.1093/cvr/cvr022
[28] Jiang HB, Wang SM, Hou LK, et al. Resveratrol inhibits cell apoptosis by suppressing long noncoding RNA (lncRNA) XLOC_014869 during lipopolysaccharide-induced acute lung injury in rats. J Thorac Dis, 2021; 13, 6409−26. doi:  10.21037/jtd-21-1113
[29] Pal S, Shankar BS, Sainis KB. Cytokines from the tumor microenvironment modulate sirtinol cytotoxicity in A549 lung carcinoma cells. Cytokine, 2013; 64, 196−207. doi:  10.1016/j.cyto.2013.07.029
[30] Ugwu FN, Yu AP, Sin TK, et al. Protective effect of unacylated ghrelin on compression-induced skeletal muscle injury mediated by SIRT1-signaling. Front Physiol, 2017; 8, 962. doi:  10.3389/fphys.2017.00962
[31] Carafa V, Nebbioso A, Cuomo F, et al. RIP1-HAT1-SIRT complex identification and targeting in treatment and prevention of cancer. Clin Cancer Res, 2018; 24, 2886−900. doi:  10.1158/1078-0432.CCR-17-3081
[32] Yeung F, Hoberg JE, Ramsey CS, et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J, 2004; 23, 2369−80. doi:  10.1038/sj.emboj.7600244
[33] Kim SE, Kim HK, Choi SM, et al. In vitro Synergy and in vivo activity of tigecycline-ciprofloxacin combination therapy against Vibrio vulnificus sepsis. Antimicrob Agents Chemother, 2019; 63, e00310−19.
[34] Da Silva LV, Ossai S, Chigbu P, et al. Antimicrobial and genetic profiles of Vibrio vulnificus and Vibrio parahaemolyticus isolated from the maryland Coastal Bays, United States. Front Microbiol, 2021; 12, 676249. doi:  10.3389/fmicb.2021.676249
[35] Elmahdi S, Dasilva LV, Parveen S. Antibiotic resistance of Vibrio parahaemolyticus and Vibrio vulnificus in various countries: a review. Food Microbiol, 2016; 57, 128−34. doi:  10.1016/j.fm.2016.02.008